Senior Lecturer in Immune Haemato-Oncology

About Us

King’s College London (KCL) is one of the top UK universities, ranked 36th in the world (Times Higher Education World Rankings 2025). KCL has over 33,000 students from some 190 countries, and over 8,500 employees.  

The Faculty of Life Sciences & Medicine (FoLSM) is configured as six Schools and the cross-cutting Centre for Education and it is located on four sites – Guy’s, St Thomas’, Waterloo and Denmark Hill.

King’s Comprehensive Cancer Centre (CCC) headed by Professor Sheila Singh is the academic arm of one of the leading cancer centres in Europe. Research at the CCC is supported by strategic investments such as the King’s partnership in the Cancer Research UK City of London Centre (CRUK CoL), CRUK RadNet, the KHP Experimental Cancer Medicine Centre (ECMC) and Breast Cancer Now Research Unit.

The Department of Haematology of the CCC is based in the Denmark Hill campus and comprises 10 research groups led by King’s academics, including several clinicians. Research includes Leukaemia & Myeloma, Lymphoma, Bone Marrow Failure & Myelodysplastic Syndromes, Clonal Haematopoiesis, Allogeneic Stem Cell Transplantation, Molecular Haematology, Sickle Cell Disease and Venous Thrombosis and is supported by flow cytometry and single cell core facilities and the Haematology Biobank.  

For an informal discussion or to find out more about the role please contact  john.strouboulis@kcl.ac.uk 

About The Role

We are seeking to appoint a Senior Lecturer to lead research and build upon successful programmes in the rapidly evolving discipline of Immune Haemato-oncology, which is key to therapeutic strategies in haematology. The department is growing and is looking to enhance its international competitiveness in this emerging area. We have active clinical and research programmes in understanding the immunobiology of haematological disease.

The postholder will help develop their independent programme of research in molecular immunology to make a substantive contribution to KCL's portfolio of research in cell and gene therapeutics, focusing on haemato-oncology, and novel diagnostic and therapeutic strategies for haematology. This post will complement strengths at King’s Haematology including bone marrow failure, haematopoiesis, myeloid malignancies, lymphoma, hemoglobinopathies and gene therapy. The postholder will also develop collaborative research across the School of Cancer & Pharmaceutical Sciences (SCPS) and the Faculty of Life Sciences and Medicine (FoLSM).

The postholder will also contribute to research training and the development and delivery of undergraduate and postgraduate education programmes within the SCPS and FoLSM.

This is a full-time post (35 hours per week), and you will be offered an indefinite contract.

Advert information